PTEN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.450300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.301170E-01
Normal-vs-Stage2
9.872500E-02
Normal-vs-Stage3
5.172000E-02
Normal-vs-Stage4
5.031600E-01
Stage1-vs-Stage2
9.141800E-01
Stage1-vs-Stage3
2.511000E-01
Stage1-vs-Stage4
5.393800E-01
Stage2-vs-Stage3
2.114200E-01
Stage2-vs-Stage4
4.933200E-01
Stage3-vs-Stage4
2.063600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.802100E-02
Normal-vs-AfricanAmerican
7.607200E-01
Normal-vs-Asian
2.472400E-02
Caucasian-vs-AfricanAmerican
5.012400E-01
Caucasian-vs-Asian
2.233200E-01
AfricanAmerican-vs-Asian
3.168600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.525240E-01
Normal-vs-Female
4.355900E-02
Male-vs-Female
5.941200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.693210E-01
Normal-vs-Age(41-60Yrs)
3.126600E-01
Normal-vs-Age(61-80Yrs)
5.483700E-02
Normal-vs-Age(81-100Yrs)
7.576800E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.967200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.844200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.869600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.041800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.161500E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.726600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.478100E-02
Normal-vs-Daily Drinker
1.138320E-02
Normal-vs-Weekly Drinker
6.411900E-02
Normal-vs-Occasional Drinker
1.875950E-01
Normal-vs-Social Drinker
2.118200E-01
Non Drinker-vs-Daily Drinker
6.827400E-01
Non Drinker-vs-Weekly Drinker
8.573400E-01
Non Drinker-vs-Occasional Drinker
1.255560E-01
Non Drinker-vs-Social Drinker
1.809780E-01
Daily Drinker-vs-Weekly Drinker
5.915400E-01
Daily Drinker-vs-Occasional Drinker
5.526500E-02
Daily Drinker-vs-Social Drinker
8.935700E-02
Weekly Drinker-vs-Occasional Drinker
2.617200E-01
Weekly Drinker-vs-Social Drinker
3.301400E-01
Occasional Drinker-vs-Social Drinker
9.464600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.776400E-02
Normal-vs-Grade 2
2.255700E-02
Normal-vs-Grade 3
3.340500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.077520E-02
Grade 1-vs-Grade 3
3.698100E-02
Grade 1-vs-Grade 4
9.776400E-02
Grade 2-vs-Grade 3
7.987200E-01
Grade 2-vs-Grade 4
2.255700E-02
Grade 3-vs-Grade 4
3.340500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.723500E-02
Normal-vs-NonDiabetic
7.536300E-02
Diabetic-vs-NonDiabetic
9.665800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.936200E-03
Normal-vs-NoPancreatitis
9.007700E-02
Pancreatitis-vs-NoPancreatitis
2.587200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.230400E-02
Normal-vs-N1
1.290440E-01
N0-vs-N1
3.571400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.534200E-02
Normal-vs-TP53-NonMutant
2.085000E-01
TP53-Mutant-vs-TP53-NonMutant
2.150200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
